Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor using electronic patient-reported outcomes in daily clinical practice (QUANARIE trial): study protocol.

Guillaume MouilletJoëlle FritzschSophie Paget-BaillyAstrid PozetIkram Es-SaadAurelia MeurisseDewi VernereyKristina MouyabiDiane BerthodFranck BonnetainAmélie AnotaAntoine Thiery-Vuillemin

Published in: Health and quality of life outcomes (2019)

ClinicalTrials.gov; Identifier: NCT03062410 ; First Posted: February 23, 2017; Last Update Posted: August 9, 2017.

Keyphrases

patient reported outcomes
study protocol
metastatic renal cell carcinoma
clinical practice
randomized controlled trial
clinical trial
open label
phase iii
physical activity
phase ii
placebo controlled
double blind
newly diagnosed